4-82429578-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_031372.4(HNRNPDL):āc.113T>Cā(p.Leu38Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,389,752 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031372.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNRNPDL | NM_031372.4 | c.113T>C | p.Leu38Pro | missense_variant | 1/8 | ENST00000295470.10 | NP_112740.1 | |
HNRNPDL | NM_001207000.1 | c.113T>C | p.Leu38Pro | missense_variant | 1/7 | NP_001193929.1 | ||
HNRNPDL | NR_003249.2 | n.648T>C | non_coding_transcript_exon_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNRNPDL | ENST00000295470.10 | c.113T>C | p.Leu38Pro | missense_variant | 1/8 | 1 | NM_031372.4 | ENSP00000295470.5 |
Frequencies
GnomAD3 genomes AF: 0.000628 AC: 95AN: 151344Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000311 AC: 6AN: 19300Hom.: 0 AF XY: 0.000405 AC XY: 4AN XY: 9884
GnomAD4 exome AF: 0.00111 AC: 1375AN: 1238290Hom.: 1 Cov.: 32 AF XY: 0.00107 AC XY: 645AN XY: 601606
GnomAD4 genome AF: 0.000627 AC: 95AN: 151462Hom.: 0 Cov.: 32 AF XY: 0.000432 AC XY: 32AN XY: 74034
ClinVar
Submissions by phenotype
Autosomal dominant limb-girdle muscular dystrophy type 1G Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 13, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 01, 2024 | The c.113T>C (p.L38P) alteration is located in exon 1 (coding exon 1) of the HNRNPDL gene. This alteration results from a T to C substitution at nucleotide position 113, causing the leucine (L) at amino acid position 38 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at